Blood pressure drug may aid in Alzheimer’s disease treatment
An FDA-approved blood pressure drug may offer benefits to Alzheimer’s disease treatment by reducing cell damage. The drug – candesartan – may be beneficial in early Alzheimer’s disease treatment, along with other Angiotensin receptor blockers (ARBs). Senior author Juan M. Saavedra said, “Our findings make sense in many ways. Hypertension reduces blood flow throughout the ...click here to read more